• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】14713

【品名】benzenesulfonyl chloride

【CA登记号】98-09-9

【 分 子 式 】C6H5ClO2S

【 分 子 量 】176.6232

【元素组成】C 40.8% H 2.85% Cl 20.07% O 18.12% S 18.16%

与该中间体有关的原料药合成路线共 19 条

合成路线1

该中间体在本合成路线中的序号:(V)

The reaction of 4-[2-(acetylamino)ethyl]phenol (I) with ethyl bromoacetate (II) by means of K2CO3 in refluxing butanone gives 4-[2-(acetylamino)ethyl]phenoxyacetic acid ethyl ester (III), which is hydrolyzed with refluxing aqueous HCl to 4-(2-aminoethyl)phenoxyacetic acid (IV). Finally, this compound is acylated with benzenesulfonyl chloride (V) by means of K2CO3 in hot water.

1 Witte, E.C.; Wolff, H.P.; Thiel, M.; Stegmeier, K.; Roesch, E.; Phenoxyalkylcarboxylic acid compounds and thrombocyte-aggregation inhibition. DE 2809377; EP 0004011; ES 478228; JP 54122250; US 4258058 .
2 Karup, G.L.; Preikschat, H.F. (GEA A/S Farmaceutisk Fabrik); Process for the preparation of 1,4-dihydropyridines and cpds. used in this process. WO 9925688 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 19989 N-(4-hydroxyphenethyl)acetamide C10H13NO2 详情 详情
(II) 16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情
(III) 34332 ethyl 2-[4-[2-(acetamido)ethyl]phenoxy]acetate C14H19NO4 详情 详情
(IV) 34333 2-[4-(2-aminoethyl)phenoxy]acetic acid C10H13NO3 详情 详情
(V) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VIII)

The hydrogenation of 4-(4-fluorophenyl)-3-(ethoxycarbonyl)-1-methylpyridinium bromide (I) with H2 over PtO2 in toluene/ethanol gives racemic (cis)-4-(4-fluorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester (rac)-(II), which is isomerized with NaOMe in refluxing toluene to yield the trans-isomer (rac)-(III). The reduction of (rac)-(III) with LiAlH4 in toluene/THF affords the hydroxymethyl compound (rac)-(IV), which is submitted to optical resolution with L-(-)-di-p-toluoyltartaric acid to provide the chiral (3S,4R)-(V). Alternatively, the optical resolution of (cis)-(rac)-(II) with D-(+)-di-p-toluoyltartaric acid gives the ester (cis)-(3R,4R)-(VI), which is isomerized with NaOMe in refluxing toluene to yield ester (trans)-(3S,4R)-(VII). Finally, this compound is reduced with LiAlH4 in toluene/THF to afford the previously reported intermediate (3S,4R)-(V). The reaction of (3S,4R)-(V) with benzenesulfonyl chloride (VIII) and dimethylethylamine in toluene gives the corresponding sulfonate (3S,4R)-(IX), which is condensed with 5-hydroxy-1,3-benzodioxole (X) by means of NaOMe in hot DMF to yield the adduct (3S,4R)-(XI). Finally, this compound is demethylated by reaction with phenyl chloroformate (XII) to afford the cyclic carbamate (3S,4R)-(XIII), which is hydrolyzed with KOH in refluxing toluene.

1 Borrett, G.T.; Ward, N.; Crowe, D.; Wells, A.S. (GlaxoSmithKline plc); Process for the preparation of paroxetine. WO 0129031 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 56453 4-(4-fluorophenyl)-3-(methoxycarbonyl)-1-methylpyridinium bromide C14H13BrFNO2 详情 详情
(II) 56454 (rac)-methyl (3R,4R)-4-(4-fluorophenyl)-1-methyl-3-piperidinecarboxylate C14H18FNO2 详情 详情
(III) 56455 (rac)-methyl (3S,4R)-4-(4-fluorophenyl)-1-methyl-3-piperidinecarboxylate C14H18FNO2 详情 详情
(IV) 43487 [(3S,4R)-4-(4-fluorophenyl)-1-methylpiperidinyl]methanol; trans-(3S)-4-(4-fluorophenyl)-1-methyl-3-piperidine methanol 105812-81-5 C13H18FNO 详情 详情
(V) 56458 [(3S,4R)-4-(4-fluorophenyl)-1-methylpiperidinyl]methanol C13H18FNO 详情 详情
(VI) 56456 methyl (3R,4R)-4-(4-fluorophenyl)-1-methyl-3-piperidinecarboxylate C14H18FNO2 详情 详情
(VII) 56457 methyl (3S,4R)-4-(4-fluorophenyl)-1-methyl-3-piperidinecarboxylate C14H18FNO2 详情 详情
(VIII) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(IX) 10986 [(3S,4R)-4-(4-fluorophenyl)-1-methylhexahydro-3-pyridinyl]methyl benzenesulfonate C19H22FNO3S 详情 详情
(X) 10985 1,3-Benzodioxol-5-ol; Sesamol 533-31-3 C7H6O3 详情 详情
(XI) 10987 (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylhexahydropyridine; 1,3-Benzodioxol-5-yl [(3S,4R)-4-(4-fluorophenyl)-1-methylhexahydro-3-pyridinyl]methyl ether C20H22FNO3 详情 详情
(XII) 13580 1-[(Chlorocarbonyl)oxy]benzene; phenyl chloroformate 1885-14-9 C7H5ClO2 详情 详情
(XIII) 43489 phenyl (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate C26H24FNO5 详情 详情

合成路线3

该中间体在本合成路线中的序号:(LIII)

The reaction of (1R,2S,3S,4S)-bicyclo[2.2.1]heptane-2,3-dicarboxylic acid 2-monomethyl ester (XLIII) with ethylchloroformate and NaN3 gives the corresponding azide (XLIV), which is submitted to degradation in the presence of benzyl alcohol to afford (1R,2S,3S,4S)-3-(benzyloxycarbonylamino)bicyclo[2.2.1]heptane-2-carboxylic acid methyl ester (XLV). The reduction of (XLV) with NaBH4 in THF gives the hydroxymethyl derivative (XLVI), which is oxidized with oxalyl chloride as before to the corresponding aldehyde (XLVII). The Wittig condensation of (XLVII) with methoxymethyl triphenylphosphonium chloride by means of t-BuOK in THF gives the vinyl ether (XLVIII), which is hydrolyzed to the corresponding aldehyde (XLIX) with formic acid. A new Wittig condensation of (XLIX) with 4-carboxybutyl triphenylphosphonium bromide as before, followed by methylation with diazomethane yields (1R,2S,3S,4S)-7-[3-(benzyloxycarbonylamino)bicyclo[2.2.1]heptan-2-yl]-5(Z)-heptenoic acid methyl ester (L). The deprotection of (L) with trifluoroacetic acid affords the 3-amino derivative (LI), which is then condensed with [14C]- or [3H]-radiolabeled benzenesulfonyl chloride (LII) to afford the radiolabeled sulfonamide ester (LIII). Finally, this compound is hydrolyzed with NaOH to the radiolabeled free acid (XIV), already obtained, which is converted to S-1452 by treatment of the Na salt with CaCl2 in methanol-water.

1 Narisada, M.; Katsuyama, Y.; Watanabe, F.; Hamada, Y.; Ohtani, M.; Nagasaki, T.; Synthesis of [14C]- and [3H]-labelled (+)-[1R-[1alpha,2alpha(Z),3beta,4alpha]]-7-[3-[(phenylsulfonyl)amino] bicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, ((+)-S-145) and its calcium salt (S-1452). J Label Compd Radiopharm 1992, 31, 1, 23-38.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IL) 14681 benzyl N-[(1S,2S,3S,4R)-3-(2-oxoethyl)bicyclo[2.2.1]hept-2-yl]carbamate C17H21NO3 详情 详情
(XIV) 14674 (Z)-7-[(1R,2S,3S,4S)-3-[(phenylsulfonyl)amino]bicyclo[2.2.1]hept-2-yl]-5-heptenoic acid C20H27NO4S 详情 详情
(XLIII) 14665 (1S,2S,3S,4R)-3-(methoxycarbonyl)bicyclo[2.2.1]heptane-2-carboxylic acid C10H14O4 详情 详情
(XLIV) 14704 methyl (1R,2S,3S,4S)-3-(azidocarbonyl)bicyclo[2.2.1]heptane-2-carboxylate C10H13N3O3 详情 详情
(XLV) 14705 methyl (1R,2S,3S,4S)-3-[[(benzyloxy)carbonyl]amino]bicyclo[2.2.1]heptane-2-carboxylate C17H21NO4 详情 详情
(XLVI) 14706 benzyl N-[(1S,2S,3S,4R)-3-(hydroxymethyl)bicyclo[2.2.1]hept-2-yl]carbamate C16H21NO3 详情 详情
(XLVII) 14707 benzyl N-[(1S,2S,3S,4R)-3-formylbicyclo[2.2.1]hept-2-yl]carbamate C16H19NO3 详情 详情
(XLVIII) 14708 benzyl N-[(1S,2S,3R,4R)-3-[(E)-2-methoxyethenyl]bicyclo[2.2.1]hept-2-yl]carbamate C18H23NO3 详情 详情
(L) 14682 methyl (Z)-7-((1R,2S,3S,4S)-3-[[(benzyloxy)carbonyl]amino]bicyclo[2.2.1]hept-2-yl)-5-heptenoate C23H31NO4 详情 详情
(LI) 14683 methyl (Z)-7-[(1R,2S,3S,4S)-3-aminobicyclo[2.2.1]hept-2-yl]-5-heptenoate C15H25NO2 详情 详情
(LII) 14684 methyl (Z)-7-[(1R,2S,3S,4S)-3-[(phenylsulfonyl)amino]bicyclo[2.2.1]hept-2-yl]-5-heptenoate C21H29NO4S 详情 详情
(LIII) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情

合成路线4

该中间体在本合成路线中的序号:

The reaction of 4-fluorophenol (I) with epichlorohydrin (II) by means of K2CO3 in refluxing acetone gives 2-(4-fluorophenoxymethyl)oxirane (III), which is submitted to an enantioselective ring opening with the Jacobsen (R,R)-catalyst yielding a mixture of the (R)-diol (IV) and unaltered epoxide (V), easily separated by column chromatography. The reaction of (IV) with tosyl chloride and pyridine in dichloromethane affords the primary monotosylate (VI), which is converted into the chiral epoxide (VII) by reaction with NaH in THF/DMF. The reaction of (VII) with allylmagnesium bromide (VIII) in ethyl ether gives the 2-hexenol derivative (IX), which is treated with benzenesulfonyl chloride and DMAP yielding the sulfonate (X). The ozonolysis of (X) with ozone in dichloromethane affords the aldehyde (XI), which is condensed with ethoxycarbonylmethylene(triphenyl)phosphorane (XII) yielding the 2-heptenoic ester (XIII). The reduction of (XIII) with diisobutylaluminum hydride (DIBAL) in toluene/dichloromethane provides the 2-hepten-1-ol (XIV), which is epoxidized with cumene hydroperoxide in the presence of diisopropyl (+)-tartrate and Ti(Oi-Pr)4 in dichloromethane to give the chiral epoxyalcohol (XV). The reaction of (XV) with triphenylphosphine/CCl4 in chloroform affords the corresponding chloride (XVI).

1 Adhikari, S.S.; Hymavathi, L.; Sadalapure, K.; Sharma, G.V.M.; Sreenivas, P.; Mhaskar, S.V.; Lalitha, S.V.S.; Chorghade, M.S.; Murugaiah, A.M.S.; Prasad, T.R.; Reddy, B.S.; Gurjar, M.K.; Reddy, V.G.; Krishna, P.R. (LeukoSite, Inc.); Substd. oxygen alicyclic cpds., including methods for synthesis thereof. WO 0001381 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(I) 19639 4-fluorophenol 371-41-5 C6H5FO 详情 详情
(II) 10146 Epichlorohydrin; 2-(Chloromethyl)oxirane 106-89-8 C3H5ClO 详情 详情
(III) 22150 2-[(4-fluorophenoxy)methyl]oxirane; 4-fluorophenyl 2-oxiranylmethyl ether 18123-82-5 C9H9FO2 详情 详情
(IV) 32985 (2R)-3-(4-fluorophenoxy)-1,2-propanediol C9H11FO3 详情 详情
(V) 32986 4-fluorophenyl (2S)oxiranylmethyl ether; (2S)-2-[(4-fluorophenoxy)methyl]oxirane 108648-25-5 C9H9FO2 详情 详情
(VI) 32987 (2S)-3-(4-fluorophenoxy)-2-hydroxypropyl 4-methylbenzenesulfonate C16H17FO5S 详情 详情
(VII) 22150 2-[(4-fluorophenoxy)methyl]oxirane; 4-fluorophenyl 2-oxiranylmethyl ether 18123-82-5 C9H9FO2 详情 详情
(VIII) 10386 Allyl(bromo)magnesium 1730-25-2 C3H5BrMg 详情 详情
(IX) 32988 (2R)-1-(4-fluorophenoxy)-5-hexen-2-ol C12H15FO2 详情 详情
(X) 32989 (1R)-1-[(4-fluorophenoxy)methyl]-4-pentenyl benzenesulfonate C18H19FO4S 详情 详情
(XI) 32990 (1R)-1-[(4-fluorophenoxy)methyl]-4-oxobutyl benzenesulfonate C17H17FO5S 详情 详情
(XII) 14182 ethyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate; (Carbethoxymethylene)triphenylphosphorane 1099-45-2 C22H21O2P 详情 详情
(XIII) 32991 ethyl (E,6R)-7-(4-fluorophenoxy)-6-[(phenylsulfonyl)oxy]-2-heptenoate C21H23FO6S 详情 详情
(XIV) 32992 (1R,4E)-1-[(4-fluorophenoxy)methyl]-6-hydroxy-4-hexenyl benzenesulfonate C19H21FO5S 详情 详情
(XV) 32993 (1R)-1-[(4-fluorophenoxy)methyl]-3-[(2R,3S)-3-(hydroxymethyl)oxiranyl]propyl benzenesulfonate C19H21FO6S 详情 详情
(XVI) 32994 (1R)-3-[(2R,3R)-3-(chloromethyl)oxiranyl]-1-[(4-fluorophenoxy)methyl]propyl benzenesulfonate C19H20ClFO5S 详情 详情

合成路线5

该中间体在本合成路线中的序号:(VII)

Protection of 3-amino-5-methylphenol (I) with phthalic anhydride (II) provided the phthalimido derivative (III), which was alkylated with ethyl 4-bromobutyrate (IV) in the presence of K2CO3 to give the corresponding ether (V). Hydrazinolysis of the phthalimido group of (V) afforded the primary amine (VI), which was condensed with benzenesulfonyl chloride (VII), yielding sulfonamide (VIII). Saponification of the ethyl ester of (VIII) gave carboxylic acid (IX). After conversion to the mixed anhydride with isobutyl chloroformate and N-methylmorpholine, treatment with methanolic ammonia furnished amide (X). This was reduced to amine (XI) using LiAlH4 in THF. Finally, reaction of (XI) with S-methylisothiouronium sulfate (XII) in refluxing EtOH provided the target guanidine.

1 Weber, I.R.; Neidlein, R.; von der Saal, W.; Grams, F.; Leinert, H.; Strein, K.; Engh, R.A.; Kucznierz, R.; Diarylsulfonamides as selective, non-peptidic thrombin inhibitors. Bioorg Med Chem Lett 1998, 8, 13, 1613.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II)) 11900 2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride 85-44-9 C8H4O3 详情 详情
(I) 31435 3-amino-5-methylphenol C7H9NO 详情 详情
(III) 31436 2-(3-hydroxy-5-methylphenyl)-1H-isoindole-1,3(2H)-dione C15H11NO3 详情 详情
(IV) 11263 ethyl 4-bromobutanoate; Ethyl 4-bromobutyrate 2969-81-5 C6H11BrO2 详情 详情
(V) 31437 ethyl 4-[3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-methylphenoxy]butanoate C21H21NO5 详情 详情
(VI) 31438 ethyl 4-(3-amino-5-methylphenoxy)butanoate C13H19NO3 详情 详情
(VII) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(VIII) 31439 ethyl 4-[3-methyl-5-[(phenylsulfonyl)amino]phenoxy]butanoate C19H23NO5S 详情 详情
(IX) 31441 4-[3-methyl-5-[(phenylsulfonyl)amino]phenoxy]butyric acid C17H19NO5S 详情 详情
(X) 31440 4-[3-methyl-5-[(phenylsulfonyl)amino]phenoxy]butanamide C17H20N2O4S 详情 详情
(XI) 31442 N-[3-(4-aminobutoxy)-5-methylphenyl]benzenesulfonamide C17H22N2O3S 详情 详情
(XII) 10272 [[Amino(imino)methyl]sulfanyl]methane 2986-19-8 C2H6N2S 详情 详情

合成路线6

该中间体在本合成路线中的序号:(XIV)

A new, more efficient synthesis has been reported for the intermediate (XVIII). The saccharin derivative (IV) was prepared by two alternative routes. Thus, 2-sulfobenzoic acid cyclic anhydride (XII) was treated with two equivalents of 2-(trifluoromethyl)aniline (II) to give the anilinium salt (XIII), which was cyclized with POCl3 to produce (IV). Also, starting from benzenesulfonyl chloride (XIV), the corresponding sulfonamide (II) was obtained by reaction with aniline (II). Ortho lithiation with n-butyllithium at low temperature, followed by CO2 quenching, afforded carboxylic acid (XVI), which upon treatment with Ac2O and methanesulfonic acid cyclized to the saccharin (IV). Then, the saccharin ring was opened by treatment with NaOMe, and subsequent treatment with methyl bromoacetate furnished diester (XVII). Finally, Claisen cyclization promoted by TiCl4 formed the key intermediate (XVIII).

1 Lee, C.; et al.; Synthetic studies toward a series of endothelin receptor antagonists. 1,1-Dioxo-2,4-diphenyl-2H-1,2-benzothiazine. 216th ACS Natl Meet (Aug. 23-27, Boston) 1998, Abst MEDI 058.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
12309 methyl 2-bromoacetate; methyl bromoacetate 96-32-2 C3H5BrO2 详情 详情
(II) 25812 2-(trifluoromethyl)phenylamine; 2-(trifluoromethyl)aniline 88-17-5 C7H6F3N 详情 详情
(III) 25813 methyl 2-[[2-(trifluoromethyl)anilino]sulfonyl]benzoate C15H12F3NO4S 详情 详情
(IV) 25814 2-[2-(trifluoromethyl)phenyl]-1H-1,2-benzisothiazole-1,1,3(2H)-trione C14H8F3NO3S 详情 详情
(XII) 25821 2-Sulfobenzoic acid anhydride; 2,1lambda(6)-benzoxathiole-1,1,3-trione 81-08-3 C7H4O4S 详情 详情
(XIII) 25822 2-[[2-(trifluoromethyl)anilino]sulfonyl]benzoic acid C14H10F3NO4S 详情 详情
(XIV) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(XV) 25823 N-[2-(trifluoromethyl)phenyl]benzenesulfonamide C13H10F3NO2S 详情 详情
(XVI) 25822 2-[[2-(trifluoromethyl)anilino]sulfonyl]benzoic acid C14H10F3NO4S 详情 详情
(XVII) 25824 methyl 2-[[(2-methoxy-2-oxoethyl)-2-(trifluoromethyl)anilino]sulfonyl]benzoate C18H16F3NO6S 详情 详情
(XVIII) 25825 methyl 4-hydroxy-1,1-dioxo-2-[2-(trifluoromethyl)phenyl]-1,2-dihydro-1lambda(6),2-benzothiazine-3-carboxylate C17H12F3NO5S 详情 详情

合成路线7

该中间体在本合成路线中的序号:(XII)

The selective monoprotection of 4-(4-piperidyl)piperidine (I) gives the carbamate (II), which is condensed with the isothiocyante (III) in chloroform to yield the N-(ethoxycarbonyl)carbothioamide (IV). Decarboxylation of (IV) by means of NaOH in ethanol affords the free thioamide (V), which is cyclized with 2-chloro-4-methyl-3-oxopentanoic acid ethyl ester (VI) by means of triethylamine in ethanol to provide the thiazole derivative (VII). Hydrolysis of theester group of (VII) with NaOH in ethanol gives the carboxylic acid (VIII), which is condensed with 3-amino-2(S)-(phenylsulfonamido)propionic acid methyl ester (IX), by means of DCC, HOBT and triethylamine in DMF yielding the protected target compound (X). Finally, this compound is hydrolyzed and deprotected by a treatment with HCl in ethanol. The intermediate 3-amino-2(S)-(phenylsulfonamido)propionic acid methyl ester (IX) has been obtained as follows: The reaction of L-asparagine (XI) with benzenesulfonyl chloride (XII) by means of NaOH in dioxane/water gives the sulfonated asparagine (XIII), which is submitted to Hofmann degradation with Br2 and NaOH in water and finally esterified with SOCl2 and methanol.

1 Forn, J.; Merlos, M.; Garcia-Rafanell, J.; Carceller, E.; Gomez, L.A.; Novel N-(thiazolyl-5-carbonyl)-beta-alanine derivatives as potent, orally active fibrinogen receptor antagonists. 216th ACS Natl Meet (Aug. 23-27, Boston) 1998, Abst MEDI 079.
2 Carceller, E.; Jimenez, P.J.; Salas, J. (J. Uriach & Cia., SA); Novel carboxamides as platelet aggregation inhibitors. WO 9846599 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 25962 4,4'-bipiperidine C10H20N2 详情 详情
(II) 25963 4,4'-bipiperidine-1-carboxylic acid tert-butyl ester C15H28N2O2 详情 详情
(III) 25964 1-[(isothiocyanatocarbonyl)oxy]ethane 16182-04-0 C4H5NO2S 详情 详情
(IV) 25965 N-[1'-(Tert-butoxycarbonyl)-4,4'-bipiperidin-1-yl-thiocarbonyl]carbamic acid ethyl ester C19H33N3O4S 详情 详情
(V) 25966 1'-(Tert-butoxycarbonyl)-4,4'-bipiperidine-1-carbothioamide C16H29N3O2S 详情 详情
(VI) 25967 ethyl 2-chloro-4-methyl-3-oxopentanoate C8H13ClO3 详情 详情
(VII) 25968 2-[1'-(Tert-butoxycarbonyl)-4,4'-bipiperidin-1-yl]-4-isopropylthiazole-5-carboxylic acid ethyl ester C24H39N3O4S 详情 详情
(VIII) 25969 2-[1'-(Tert-butoxycarbonyl)-4,4'-bipiperidin-1-yl]-4-isopropylthiazole-5-carboxylic acid C22H35N3O4S 详情 详情
(IX) 25970 methyl (2S)-3-amino-2-[(phenylsulfonyl)amino]propanoate C10H14N2O4S 详情 详情
(X) 25971 (2(S)-(Benzenesulfonamido)-3-[2-[4-[1-tert-butoxycarbonyl)piperidin-4-yl]piperidin-4-yl]-4-isopropylthiazol-5-ylcarboxamido]propionic acid methyl ester; (2(S)-(Benzenesulfonamido)-3-[2-[4-[1-tert-butoxycarbonyl)piperidin-4-yl]piperidin-4-yl]-4-isopropylthiazol-5-ylcarboxamido]propionic acid methyl ester C32H47N5O7S2 详情 详情
(XI) 25972 S-(+)-Asparagine; S-(+)-2-Aminosuccinamic acid; L-Asparagine 70-47-3 C4H8N2O3 详情 详情
(XII) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(XIII) 25973 (2S)-4-amino-4-oxo-2-[(phenylsulfonyl)amino]butyric acid C10H12N2O5S 详情 详情

合成路线8

该中间体在本合成路线中的序号:(II)

The sulfonation of 3-aminobenzonitrile (I) with benzenesulfonyl chloride (II) by means of triethylamine in dichloromethane gives the sulfonamide (III), which is nitrated with HNO3 in acetic anhydride yielding 4-nitro-3-(phenyl sulfonamido)benzonitrile (IV). The reduction of (IV) with SnCl2 in hot ethanol affords the corresponding 4-amino derivative (V), which is finally condensed with 2-bromophenyl isocyanate (VI) in hot DMF.

1 Widdowson, K.L.; Veber, D.F.; Jurewicz, A.J.; Rutledge, M.C. Jr.; Hertzberg, R.P. (SmithKline Beecham plc); IL-8 receptor antagonists. EP 0809492; JP 1999503110; US 5780483; WO 9625157 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 28662 3-aminobenzonitrile 2237-30-1 C7H6N2 详情 详情
(II) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(III) 28663 N-(3-cyanophenyl)benzenesulfonamide C13H10N2O2S 详情 详情
(IV) 28664 N-(5-cyano-2-nitrophenyl)benzenesulfonamide C13H9N3O4S 详情 详情
(V) 28665 N-(2-amino-5-cyanophenyl)benzenesulfonamide C13H11N3O2S 详情 详情
(VI) 28666 1-bromo-2-isocyanatobenzene 1592-00-3 C7H4BrNO 详情 详情

合成路线9

该中间体在本合成路线中的序号:(II)

The sulfonation of 3-aminobenzonitrile (I) with benzenesulfonyl chloride (II) by means of triethylamine in dichloromethane gives the sulfonamide (III), which is nitrated with HNO3 in acetic anhydride yielding 4-nitro-3-(phenyl sulfonamido)benzonitrile (IV). The reduction of (IV) with SnCl2 in hot ethanol affords the corresponding 4-amino derivative (V), which is finally condensed with 2,3-dichlorophenyl isocyanate (VI) in hot DMF.

1 Widdowson, K.L.; Veber, D.F.; Jurewicz, A.J.; Rutledge, M.C. Jr.; Hertzberg, R.P. (SmithKline Beecham plc); IL-8 receptor antagonists. EP 0809492; JP 1999503110; US 5780483; WO 9625157 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 28662 3-aminobenzonitrile 2237-30-1 C7H6N2 详情 详情
(II) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(III) 28663 N-(3-cyanophenyl)benzenesulfonamide C13H10N2O2S 详情 详情
(IV) 28664 N-(5-cyano-2-nitrophenyl)benzenesulfonamide C13H9N3O4S 详情 详情
(V) 28665 N-(2-amino-5-cyanophenyl)benzenesulfonamide C13H11N3O2S 详情 详情
(VI) 28667 1,2-dichloro-3-isocyanatobenzene 41195-90-8 C7H3Cl2NO 详情 详情

合成路线10

该中间体在本合成路线中的序号:(II)

The condensation of L-asparagine (I) with benzenesulfonyl chloride (II) in the presence of NaOH gave sulfonamide (III). Subsequent Hofmann rearrangement of (III) employing sodium hypobromite produced the diaminopropionic acid derivative (IV), which was protected as the tert-butyl ester (V) using isobutylene in the presence of H2SO4. Condensation of methyl 4-aminobenzoate (VI) with bis(2-chloroethyl)amine (VII) in refluxing butanol yielded the arylpiperazine (VIII), which was protected with di tert-butyl dicarbonate to give the corresponding carbamate (IX). Basic hydrolysis of the methyl ester of (IX) provided carboxylic acid (X). This was then coupled with amine (V) using benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP) to afford amide (XI). Finally, deprotection of the tert-butyl ester and BOC group of (XI) with trifluoroacetic acid furnished the title compound.

1 Egbertson, M.S.; Turchi, L.M.; Hartman, G.D.; Halczenko, W.; Whitman, D.B.; Perkins, J.J.; Krause, A.E.; Ihle, N.; Claremon, D.A.; Hoffman, W.; Duggan, M.E. (Merck & Co., Inc.); Fibrinogen receptor antagonists. EP 0673247; JP 1996504194; WO 9412181 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 25972 S-(+)-Asparagine; S-(+)-2-Aminosuccinamic acid; L-Asparagine 70-47-3 C4H8N2O3 详情 详情
(II) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(III) 25973 (2S)-4-amino-4-oxo-2-[(phenylsulfonyl)amino]butyric acid C10H12N2O5S 详情 详情
(IV) 31422 (2S)-3-amino-2-[(phenylsulfonyl)amino]propionic acid C9H12N2O4S 详情 详情
(V) 31423 tert-butyl (2S)-3-amino-2-[(phenylsulfonyl)amino]propanoate C13H20N2O4S 详情 详情
(VI) 20537 methyl 4-aminobenzoate 619-45-4 C8H9NO2 详情 详情
(VII) 21583 2-chloro-N-(2-chloroethyl)-1-ethanamine; Bis(2-chloroethyl)amine; 1,1'-iminobis(2-chloroethane); N,N-bis(2-chloroethyl)amine 821-48-7 C4H9Cl2N 详情 详情
(VIII) 31424 methyl 4-(1-piperazinyl)benzoate C12H16N2O2 详情 详情
(IX) 31425 tert-butyl 4-[4-(methoxycarbonyl)phenyl]-1-piperazinecarboxylate C17H24N2O4 详情 详情
(X) 31426 4-[4-(tert-butoxycarbonyl)-1-piperazinyl]benzoic acid C16H22N2O4 详情 详情
(XI) 31427 tert-butyl 4-[4-[([(2S)-3-(tert-butoxy)-3-oxo-2-[(phenylsulfonyl)amino]propyl]oxy)carbonyl]phenyl]-1-piperazinecarboxylate C29H39N3O8S 详情 详情

合成路线11

该中间体在本合成路线中的序号:

Ethyl 6-azaindole-3-carboxylate (I) was formylated using dichloromethyl methyl ether and AlCl3 to provide aldehyde (II). Nitrogen protection in (II) with benzenesulfonyl chloride and NaH gave sulfonyl derivative (III). Subsequent Wittig condensation of (III) with (ethoxycarbonylmethylene)triphenyl phosphorane produced the unsaturated ester (IV). Finally, removal of the benzenesulfonyl protecting group of (IV) was effected by treatment with ethanolic NaOEt.

1 Le Hyaric, M.; Doisy, X.; Dekhane, M.; et al.; Synthesis and benzodiazepine receptor (omega receptor) affinities of 3-substituted derivatives of pyrrolo[2,3-c]pyridine-5-carboxylate, a novel class of omega1 selective ligands. Bioorg Med Chem 1999, 7, 5, 921.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
14182 ethyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate; (Carbethoxymethylene)triphenylphosphorane 1099-45-2 C22H21O2P 详情 详情
14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
40668 dichloro(methoxy)methane; dichloromethyl methyl ether 4885-02-3 C2H4Cl2O 详情 详情
(I) 26182 ethyl 1H-pyrrolo[2,3-c]pyridine-5-carboxylate C10H10N2O2 详情 详情
(II) 26183 ethyl 3-formyl-1H-pyrrolo[2,3-c]pyridine-5-carboxylate C11H10N2O3 详情 详情
(III) 26184 ethyl 3-formyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-c]pyridine-5-carboxylate C17H14N2O5S 详情 详情
(IV) 26185 ethyl 3-[(E)-3-ethoxy-3-oxo-1-propenyl]-1-(phenylsulfonyl)-1H-pyrrolo[2,3-c]pyridine-5-carboxylate C21H20N2O6S 详情 详情

合成路线12

该中间体在本合成路线中的序号:(I)

Reaction of benzenesulfonyl chloride (I) with methylamine afforded sulfonamide (II). Regioselective ortho lithiation of (II) with n-butyllithium, followed by condensation with 3-methylbenzaldehyde (III) gave carbinol (IV), which was cyclized to the sultam (V) by treatment with concentrated H2SO4. The desired (S)-enantiomer was finally isolated by chiral HPLC.

1 Johnson, S.C.; Yan, S.; Mayasundari, A.; Mao, J.; Baker, D.C. (University of Tennessee, Knoxville); Methods of synthesizing sultams and anti-viral compsns.. WO 0004004 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(II) 41076 N-methylbenzenesulfonamide 5183-78-8 C7H9NO2S 详情 详情
(III) 41077 3-methylbenzaldehyde 620-23-5 C8H8O 详情 详情
(IV) 41078 2-[hydroxy(3-methylphenyl)methyl]-N-methylbenzenesulfonamide C15H17NO3S 详情 详情
(V) 41079 2-methyl-3-(3-methylphenyl)-2,3-dihydro-1H-1,2-benzisothiazole-1,1-dione C15H15NO2S 详情 详情

合成路线13

该中间体在本合成路线中的序号:(VI)

The alkylation of 2-phenyl-4-pentenenitrile (I) with 2-(trimethylsilyl)ethoxymethyl chloride (II) in the presence of LDA afforded (III), which was reduced to aldehyde (IV) by means of DIBAL. Reductive amination of (III) with methylamine and NaBH(OAc)3 produced amine (V) and subsequent condensation with benzenesulfonyl chloride (VI) yielded sulfonamide (VII). A two-step oxidation of (VII) with osmium tetroxide and N-methylmorpholine-N-oxide, followed by sodium periodate cleavage of the resulting diol (VIII) generated aldehyde (IX). Further reductive amination of (IX) with piperidine derivative (X) gave adduct (XI). The (trimethylsilyl)ethoxy protecting group of (XI) was finally cleaved by means of trifluoroacetic acid to furnish the title compound.

1 Cladwell, C.G.; Chen, P.; Donnelly, K.F.; et al.; Discovery of potent human CCR5 antagonists for the treatment of HIV-1 infection-IV. 219th ACS Natl Meet (March 26 2000, San Francisco) 2000, Abst MEDI 120.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 39738 2-phenyl-3-butenenitrile C10H9N 详情 详情
(II) 27243 [2-(chloromethoxy)ethyl](trimethyl)silane 76513-69-4 C6H15ClOSi 详情 详情
(III) 39739 2-phenyl-2-[[2-(trimethylsilyl)ethoxy]methyl]-3-butenenitrile C16H23NOSi 详情 详情
(IV) 39740 2-phenyl-2-[[2-(trimethylsilyl)ethoxy]methyl]-4-pentenal C17H26O2Si 详情 详情
(V) 39741 N-methyl-N-(2-phenyl-2-[[2-(trimethylsilyl)ethoxy]methyl]-4-pentenyl)amine; N-methyl-2-phenyl-2-[[2-(trimethylsilyl)ethoxy]methyl]-4-penten-1-amine C18H31NOSi 详情 详情
(VI) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(VII) 39742 N-methyl-N-(2-phenyl-2-[[2-(trimethylsilyl)ethoxy]methyl]-4-pentenyl)benzenesulfonamide C24H35NO3SSi 详情 详情
(VIII) 39743 N-(4,5-dihydroxy-2-phenyl-2-[[2-(trimethylsilyl)ethoxy]methyl]pentyl)-N-methylbenzenesulfonamide C24H37NO5SSi 详情 详情
(IX) 39744 N-methyl-N-(4-oxo-2-phenyl-2-[[2-(trimethylsilyl)ethoxy]methyl]butyl)benzenesulfonamide C23H33NO4SSi 详情 详情
(X) 39745 benzyl ethyl(4-piperidinyl)carbamate C15H22N2O2 详情 详情
(XI) 39746 benzyl ethyl[1-(4-[methyl(phenylsulfonyl)amino]-3-phenyl-3-[[2-(trimethylsilyl)ethoxy]methyl]butyl)-4-piperidinyl]carbamate C38H55N3O5SSi 详情 详情

合成路线14

该中间体在本合成路线中的序号:(XII)

Reductive amination of 2,5-dimethyl-2-phenylhex-4-enal (X) with methylamine and NaBH3 gives the expected secondary amine as a racemic mixture that is separated by means of mandelic acid, yielding the desired isomer (XI). The sulfonylation of the resulting amine (XI) with benzenesulfonyl chloride (XII) provided sulfonamide (XIII). Dihydroxylation with N-methylmorpholine-N-oxide in the presence of a catalytic amount of osmium tetroxide gave rise to diol (XIV), which was oxidatively cleaved to aldehyde (XV) by means of sodium periodate. Finally, reductive condensation between aldehyde (XV) and piperidine (VI) furnished the title compound.

1 Chen, P.; Dorn, C.P. Jr.; Caldwell, C.G.; et al.; Synthesis and evaluation of CCR5 antagonists having potent in vitro antiviral activity. 220th ACS Natl Meet (Aug 20 2000, Washington DC) 2000, Abst MEDI 85.
2 Finke, P.E.; Mills, S.G.; Caldwell, C.G.; MacCoss, M.; Wang, L.; Kothandaraman, S.; Kim, D.; Oates, B. (Merck & Co., Inc.); Cyclic amine modulators of chemokine receptor activity. EP 1052992; US 6140349; WO 9938514 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VI) 43905 4-nitrobenzyl allyl(4-piperidinyl)carbamate C16H21N3O4 详情 详情
(X) 43906 tert-butyl 4-([[(4-nitrobenzyl)oxy]carbonyl]amino)-1-piperidinecarboxylate C18H25N3O6 详情 详情
(XI) 43907 2,5-dimethyl-2-phenyl-4-hexenal C14H18O 详情 详情
(XII) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(XIII) 43908 (2S)-N,2,5-trimethyl-2-phenyl-4-hexen-1-amine; N-[(2S)-2,5-dimethyl-2-phenyl-4-hexenyl]-N-methylamine C15H23N 详情 详情
(XIV) 43909 N-[(2S)-2,5-dimethyl-2-phenyl-4-hexenyl]-N-methylbenzenesulfonamide C21H27NO2S 详情 详情
(XV) 43910 N-[(2S)-4,5-dihydroxy-2,5-dimethyl-2-phenylhexyl]-N-methylbenzenesulfonamide C21H29NO4S 详情 详情

合成路线15

该中间体在本合成路线中的序号:(II)

Protection of 5-methoxyindole (I) with benzenesulfonyl chloride (II) in the presence of NaH affords the N-sulfonyl indole (III). Acylation of the 2-lithio derivative of (III) with benzoyl chloride (IV) gives rise to ketone (V). Finally, removal of the phenylsulfonyl protecting group of (V) is achieved by either basic hydrolysis or by treatment with tetrabutylammonium fluoride.

1 Hufsky, H.; Pongratz, H.; Mahboobi, S.; et al.; Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents. J Med Chem 2001, 44, 26, 4535.
2 Teller, S.; Pongratz, H.; Mahboobi, S.; et al.; Bis(1H-2-indolyl) methanones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase. J Med Chem 2002, 45, 5, 1002.
3 Burger, A.; Mahboobi, S.; Pongratz, H.; Hufsky, H.; Böhmer, F.-D.; Beckers, T.; Klenner, T.; Baasner, S.; Frieser, M.; Hockemeyer, J.; Fiebig, H.-H. (Asta Medica AG); 2-Acyl indol derivs. and their use as anti-tumour agents. DE 10020852; WO 0182909 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 25902 1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole 1006-94-6 C9H9NO 详情 详情
(II) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(III) 57928 5-methoxy-1-(phenylsulfonyl)-1H-indole; methyl 1-(phenylsulfonyl)-1H-indol-5-yl ether C15H13NO3S 详情 详情
(IV) 10463 Benzoyl chloride 98-88-4 C7H5ClO 详情 详情
(V) 57929 [5-methoxy-1-(phenylsulfonyl)-1H-indol-2-yl](phenyl)methanone C22H17NO4S 详情 详情

合成路线16

该中间体在本合成路线中的序号:(V)

N-Boc-pyrrolidine-3-carboxylic acid (II) was obtained by saponification of the corresponding methyl ester (I) with NaOH. Curtius rearrangement of acid (II) using diphenyl phosphoazidate, followed by trapping the resultant isocyanate with benzyl alcohol, produced carbamate (III). Deprotection of the benzyl carbamate (III) by hydrogenation over Pd/C gave amine (IV), which was acylated with benzenesulfonyl chloride (V) to form sulfonamide (VI). Removal of the Boc group of (VI) was then effected by treatment with trifluoroacetic acid. The resulting amine (VII) was converted to the title cyanamide by treatment with cyanogen bromide.

1 Rodan, S.B.; Falgueyret, J.-P.; Wesolowski, G.; Oballa, R.M.; Rydzewski, R.M.; Okamoto, O.; Prasit, P.; Riendeau, D.; Aubin, Y.; Percival, M.D.; Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L. J Med Chem 2001, 44, 1, 94.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 46931 1-(tert-butyl) 3-methyl 1,3-pyrrolidinedicarboxylate C11H19NO4 详情 详情
(II) 46932 1-(tert-butoxycarbonyl)-3-pyrrolidinecarboxylic acid C10H17NO4 详情 详情
(III) 46933 tert-butyl 3-[[(benzyloxy)carbonyl]amino]-1-pyrrolidinecarboxylate C17H24N2O4 详情 详情
(IV) 46934 3-amino-1-N-Boc-pyrrolidine; tert-butyl 3-amino-1-pyrrolidinecarboxylate C9H18N2O2 详情 详情
(V) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(VI) 46935 tert-butyl 3-[(phenylsulfonyl)amino]-1-pyrrolidinecarboxylate C15H22N2O4S 详情 详情
(VII) 46936 N-(3-pyrrolidinyl)benzenesulfonamide C10H14N2O2S 详情 详情

合成路线17

该中间体在本合成路线中的序号:(VII)

Treatment of aniline (I) with hexafluoroacetone trihydrate (II) and p-toluenesulfonic acid affords derivative (III), which is then derivatized with trifluoroacetic anhydride (IV) to provide trifluoroacetanilide derivative (V). Reduction of (V) by means of LiAlH4 in refluxing THF yields N-trifluoroethylaniline derivative (VI), which is finally converted into the target sulfonamide by reaction with benzenesulfonyl chloride (VII) in pyridine.

1 Shan, B. (Tularik Inc.); Compsns. and methods for raising HDL cholesterol levels. WO 0103705 .
2 Liu, J.; Li, L.; Cutler, S.T.; Zhu, L.; Shan, B.; Medina, J.C.; Hasegawa, H.; Lustig, K. (Tularik Inc.); LXR modulators. EP 1161233; WO 0054759 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12294 Aniline; Phenylamine 62-53-3 C6H7N 详情 详情
(II) 44260 1,1,1,3,3,3-hexafluoroacetone 684-16-2 C3F6O 详情 详情
(III) 50005 2-(4-Aminophenyl)-1,1,1,3,3,3-hexafluoro-2-propanol; 4-(Hexafluoro-2-hydroxyisopropyl)aniline 722-92-9 C9H7F6NO 详情 详情
(IV) 33862 trifluoroacetic anhydride 407-25-0 C4F6O3 详情 详情
(V) 50006 2,2,2-trifluoro-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]acetamide C11H6F9NO2 详情 详情
(VI) 50007 1,1,1,3,3,3-hexafluoro-2-[4-[(2,2,2-trifluoroethyl)amino]phenyl]-2-propanol C11H8F9NO 详情 详情
(VII) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情

合成路线18

该中间体在本合成路线中的序号:(II)

The target compound is obtained by sulfonylation of aniline (I) with benzenesulfonyl chloride (II) in MeOH.

1 Shan, B. (Tularik Inc.); Compsns. and methods for raising HDL cholesterol levels. WO 0103705 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 49999 1,1,1,3,3,3-hexafluoro-2-[4-(methylamino)phenyl]-2-propanol C10H9F6NO 详情 详情
(II) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情

合成路线19

该中间体在本合成路线中的序号:(I)

 

1 Lara Ochoa JMF, De La Torre Guria JA, Franco Andrade F.2000. Improved procedure for the prepration of 4—hydroxy- 2-methyl-N-(5-methyl-2-thiazolyl )-2 H-l,2-benaothiazinr3-carboxamide l,l-choxide(mdoxiatm). MX 9908522
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(III) 66517 diethyl 2-(N-methylphenylsulfonamido)malonate   C14H19NO6S 详情 详情
(I) 14713 benzenesulfonyl chloride 98-09-9 C6H5ClO2S 详情 详情
(II) 41076 N-methylbenzenesulfonamide 5183-78-8 C7H9NO2S 详情 详情
(IV) 19537 methyl 4-hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1lambda(6),2-benzothiazine-3-carboxylate C11H11NO5S 详情 详情
Extended Information